Select Page

March 18, 2015 – Tarrytown, N.Y., – PsychoGenics announced today that it has obtained a license from the University of California, San Diego School of Medicine to two of their α-synuclein transgenic mouse models, over-expressing human wild type α-synuclein under control of the PDGF-promoter and the murine Thy-1 promoter. Both models are established and accepted as extremely valuable tools to research the contribution of α-synuclein in the pathogenesis of Parkinson’s disease.